Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05268666 |
| Title | A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Jubilant Therapeutics Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Sarah Cannon Research Institute at HealthOne | COMPLETED | Denver | Colorado | 82018 | United States | Details |
| The Christ Hospital | RECRUITING | Cincinnati | Ohio | 45219 | United States | Details |
| Tennessee Oncology, PLLC | COMPLETED | Nashville | Tennessee | 37203 | United States | Details |
| NEXT Virginia, LLC | COMPLETED | Fairfax | Virginia | 22031 | United States | Details |